Radiation-induced bystander signalling in cancer therapy

od Prise, Kevin M., O'Sullivan, Joe M.
Izdano 2009

Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy

od Nugent, Brenda, Lewis, Sian, O'Sullivan, Joe M
izdano v Cochrane Database Syst Rev (2013)

What is the Role of the Bystander Response in Radionuclide Therapies?

od Brady, Darren, O’Sullivan, Joe M., Prise, Kevin M.
Izdano 2013

Opportunities for research in molecular radiotherapy

od Flux, Glenn D, O'Sullivan, Joe, Gaze, Mark N, Prise, Kevin M
izdano v Br J Radiol (2017)

An exploration of men’s experiences of undergoing active surveillance for favourable-risk prostate cancer: A mixed methods study protocol

od Ruane-McAteer, Eimear, O’Sullivan, Joe, Porter, Sam, Venderbos, Lionne, Prue, Gillian
izdano v BMC Cancer (2016)

Fiducial marker guided prostate radiotherapy: a review

od O'Neill, Angela G M, Jain, Suneil, Hounsell, Alan R, O'Sullivan, Joe M
izdano v Br J Radiol (2016)

A study of the biological effects of modulated 6 MV radiation fields

od Butterworth, Karl T, McGarry, Conor K, O’Sullivan, Joe M, Hounsell, Alan R, Prise, Kevin M
Izdano 2010

A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy

od Haseen, Farhana, Murray, Liam J, O'Neill, Roisin F, O'Sullivan, Joe M, Cantwell, Marie M
Izdano 2010

OUT-OF-FIELD CELL SURVIVAL FOLLOWING EXPOSURE TO INTENSITY-MODULATED RADIATION FIELDS

od Butterworth, Karl T., McGarry, Conor K., Trainor, Colman, O'Sullivan, Joe M., Hounsell, Alan R., Prise, Kevin M.
Izdano 2011

Exercise for advanced prostate cancer: a multicomponent, feasibility, trial protocol for men with metastatic castrate-resistant prostate cancer (EXACT)

od Brown, Malcolm, Murphy, Marie, McDermott, Lauri, McAneney, Helen, O’Sullivan, Joe M., Jain, Suneil, Prue, Gillian
izdano v Pilot Feasibility Stud (2019)

The risk of cardiovascular disease in prostate cancer patients receiving androgen deprivation therapies.

od Cardwell, Chris R., O’Sullivan, Joe M., Jain, Suneil, Harbinson, Mark T., Cook, Michael B., Hicks, Blánaid M., Menamin, Úna C. Mc
izdano v Epidemiology (2020)

DNA Damage Responses following Exposure to Modulated Radiation Fields

od Trainor, Colman, Butterworth, Karl T., McGarry, Conor K., McMahon, Stephen J., O’Sullivan, Joe M., Hounsell, Alan R., Prise, Kevin M.
Izdano 2012

The mediastinal staging accuracy of 18F-Fluorodeoxyglycose Positron Emission Tomography / Computed Tomography in non-small cell lung cancer with variable time intervals to surgery.

od Booth, Karen, Hanna, Gerard G, McGonigle, Niall, McManus, Kieran G, McGuigan, James, O’Sullivan, Joe, Lynch, Tom, McAleese, Jonathan
Izdano 2013

A Kinetic-Based Model of Radiation-Induced Intercellular Signalling

od McMahon, Stephen J., Butterworth, Karl T., Trainor, Colman, McGarry, Conor K., O’Sullivan, Joe M., Schettino, Giuseppe, Hounsell, Alan R., Prise, Kevin M.
Izdano 2013

ELEVATION OF C-FLIP IN CASTRATE-RESISTANT PROSTATE CANCER ANTAGONIZES THERAPEUTIC RESPONSE TO ANDROGEN-RECEPTOR TARGETED THERAPY

od McCourt, Clare, Maxwell, Pamela, Mazzucchelli, Roberta, Montironi, Rodolfo, Scarpelli, Marina, Salto-Tellez, Manuel, O’Sullivan, Joe M., Longley, Daniel B., Waugh, David J.J.
Izdano 2012

Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy

od Denis-Bacelar, Ana M, Chittenden, Sarah J, McCready, V Ralph, Divoli, Antigoni, Dearnaley, David P, O’Sullivan, Joe M, Johnson, Bernadette, Flux, Glenn D
izdano v Br J Radiol (2018)

A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy

od Lyons, Ciara A., King, Raymond B., Osman, Sarah O.S., McMahon, Stephen J., O’Sullivan, Joe M., Hounsell, Alan R., Jain, Suneil, McGarry, Conor K.
izdano v Radiat Oncol (2017)

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

od Heidenreich, Axel, Gillessen, Silke, Heinrich, Daniel, Keizman, Daniel, O’Sullivan, Joe M., Carles, Joan, Wirth, Manfred, Miller, Kurt, Reeves, John, Seger, Monica, Nilsson, Sten, Saad, Fred
izdano v BMC Cancer (2019)

Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis

od McCourt, Clare M., McArt, Darragh G., Mills, Ken, Catherwood, Mark A., Maxwell, Perry, Waugh, David J., Hamilton, Peter, O'Sullivan, Joe M., Salto-Tellez, Manuel
Izdano 2013

Phase I/II trials of (186)Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival

od Denis-Bacelar, Ana M., Chittenden, Sarah J., Dearnaley, David P., Divoli, Antigoni, O’Sullivan, Joe M., McCready, V. Ralph, Johnson, Bernadette, Du, Yong, Flux, Glenn D.
izdano v Eur J Nucl Med Mol Imaging (2016)